NRX Pharmaceuticals's total assets for Q1 2026 were $11.90M, a decrease of -8.13% from the previous quarter. NRXP total liabilities were $25.72M for the fiscal quarter, a -10.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.